In patients with moderate infection, CD8+ TRM cells alleviate inflammation through CXCR6-mediated virus clearance, while the expression of CD8+ TRM cells is unstable and reduced in patients with severe infection, leading to viral replication (88) (Figure 4). This evidence concerns the gene CD8A and infection.